Inhaled Methoxyflurane Avoids IV Sedation in Half of Prehospital Fractures

Rethinking Prehospital Analgesia for Extremity Trauma

Managing acute traumatic limb injuries in the prehospital environment requires rapid pain control and immediate manipulation and reduction to restore alignment and prevent neurovascular compromise. Traditionally, emergency medical teams rely on intravenous procedural sedation or potent opioids like fentanyl and sufentanil to facilitate these painful interventions [1, 2]. However, establishing intravenous access and monitoring sedated patients in austere or transport settings is resource-intensive and can delay critical care [3]. To circumvent these logistical hurdles, prehospital services have increasingly explored portable, non-intravenous options, including inhaled analgesics like methoxyflurane, which offer rapid onset and self-administration capabilities [4, 5]. A retrospective review of helicopter emergency medical services now provides concrete data on whether this inhaled agent can effectively replace intravenous sedation for the field reduction of acute fractures and dislocations.

Evaluating Methoxyflurane in the Field

Prehospital manipulation and reduction of traumatic limb injuries is often necessary before hospital transfer to restore anatomical alignment, reduce bleeding, and limit secondary nerve or blood vessel damage. Because this process is intensely painful, many emergency systems default to intravenous procedural sedation, a resource-heavy intervention that is not universally available in the field. Inhaled methoxyflurane is a portable, self-administered analgesic utilized within UK Helicopter Emergency Medical Services, but its viability as a standalone agent for prehospital manipulation and reduction remains poorly defined. To evaluate its clinical utility, researchers conducted a retrospective observational review of trauma patients treated by the East Anglian Air Ambulance between January 1, 2019, and May 31, 2023. The investigators focused on patients who received inhaled methoxyflurane to facilitate the prehospital reduction of an acute limb injury. The primary outcome was successful manipulation and reduction using inhaled methoxyflurane without escalation to intravenous procedural sedation. Conversely, failure was defined as the inability to reduce the injury or the subsequent need for intravenous sedation. To identify which clinical factors influenced these outcomes, the research team used multivariable logistic regression, a statistical model that isolates the impact of individual variables like age, sex, and anatomical site while controlling for other factors. All data were analyzed in R and reported using adjusted odds ratios (aOR) with 95% confidence intervals (95% CI).

Cohort Characteristics and Reduction Success Rates

During the four-year study period, emergency medical teams attended to 7,765 patients. Of these individuals, 788 received inhaled methoxyflurane for pain management in the field, and 309 met the strict inclusion criteria for the final analysis. This specific cohort had a median age of 48 years (interquartile range: 27 to 67 years), and the sex distribution was relatively even, with 160 of the 309 included patients (51.8%) being male. The primary efficacy analysis demonstrated that a non-intravenous approach is viable for a significant portion of trauma cases. Specifically, successful manipulation and reduction was achieved with inhaled methoxyflurane in 168 out of 309 cases (54.4%). For the remaining patients, the inhaled analgesic alone was insufficient to facilitate the procedure. Among the 141 failures, 127 patients (90.1%) ultimately required intravenous sedation to achieve proper limb alignment. From a safety perspective, the use of this inhaled agent in the prehospital environment appeared highly favorable. The researchers reported that no clinically important adverse events were recorded during the administration of inhaled methoxyflurane or the subsequent reduction procedures. For practicing physicians and emergency medical directors, these data indicate that inhaled methoxyflurane can safely spare more than half of extremity trauma patients from the risks, monitoring requirements, and logistical delays associated with field-administered intravenous sedation.

Clinical Predictors: Which Patients Benefit Most?

To help clinicians identify which patients are most likely to tolerate prehospital manipulation and reduction without intravenous sedation, the researchers analyzed several independent variables. The multivariable analysis revealed that increasing age was independently associated with success, yielding an adjusted odds ratio of 1.03 per year (95% CI 1.02-1.05). This indicates a slight but steady increase in procedural tolerance for every additional year of patient age. Baseline pain management before the reduction attempt also heavily influenced outcomes. Prior administration of an opioid alone was independently associated with success (aOR 2.50; 95% CI 1.25-5.11). Furthermore, prior administration of an opioid combined with paracetamol was independently associated with success (aOR 2.19; 95% CI 1.16-4.18). For the practicing physician, these data suggest that establishing foundational analgesia before administering inhaled methoxyflurane more than doubles the likelihood of avoiding intravenous sedation. The anatomical location of the fracture or dislocation served as another major predictor of procedural outcomes. Patella injuries were independently associated with success, demonstrating an exceptionally high adjusted odds ratio of 30.12 (95% CI 5.51-564.57). In stark contrast, femoral and tibia/fibula injuries had lower odds of success, likely reflecting the substantial muscle spasms and mechanical force involved in reducing major long bones. Despite these clear statistical patterns, the authors emphasize that the associations between success and older age, pre-reduction analgesia, and patella injury are non-causal and should be interpreted cautiously. While these variables can help emergency medical teams risk-stratify patients in the field, they do not guarantee success. Clinicians must remain prepared to escalate to intravenous procedural sedation when inhaled methoxyflurane proves insufficient to overcome the pain and muscle tension of acute extremity trauma.

References

1. Fu Y, Liu Q, Nie H. Efficacy of opioids for traumatic pain in the emergency department: a systematic review and Bayesian network meta-analysis. Frontiers in Pharmacology. 2023. doi:10.3389/fphar.2023.1209131

2. Serra S, Spampinato MD, Riccardi A, et al. Intranasal Fentanyl for Acute Pain Management in Children, Adults and Elderly Patients in the Prehospital Emergency Service and in the Emergency Department: A Systematic Review. Journal of Clinical Medicine. 2023. doi:10.3390/jcm12072609

3. Grunt MND, Jong BD, Hollmann MW, Ridderikhof ML, Weenink RP. Parenteral, Non-Intravenous Analgesia in Acute Traumatic Pain—A Narrative Review Based on a Systematic Literature Search. Journal of Clinical Medicine. 2024. doi:10.3390/jcm13092560

4. Porter K, Siddiqui MK, Sharma I, Dickerson S, Eberhardt A. Management of trauma pain in the emergency setting: low-dose methoxyflurane or nitrous oxide? A systematic review and indirect treatment comparison. Journal of Pain Research. 2017. doi:10.2147/jpr.s150600

5. Porter K, Dayan AD, Dickerson S, Middleton PM. The role of inhaled methoxyflurane in acute pain management. Open Access Emergency Medicine. 2018. doi:10.2147/oaem.s181222